Ortin Laboratories is currently trading at Rs. 10.16, up by 0.48 points or 4.96% from its previous closing of Rs. 9.68 on the BSE.
The scrip opened at Rs. 10.16 and has touched a high and low of Rs. 10.16 and Rs. 9.80 respectively. So far 6500 shares were traded on the counter.
The BSE group ‘T’ stock of face value Rs. 10 has touched a 52 week high of Rs. 22.90 on 19-Sep-2018 and a 52 week low of Rs. 8.20 on 04-Sep-2019.
Last one week high and low of the scrip stood at Rs. 10.16 and Rs. 8.20 respectively. The current market cap of the company is Rs. 16.60 crore.
The promoters holding in the company stood at 34.84%, while Non-Institutions held 65.16%.
US Food and Drug Administration (USFDA) has completed inspection at Ortin Laboratories, Unit-II Malkapur Village, Choutuppal Mandal, Nalgonda District in the state of Telangana. The inspection has been completed on September 06, 2019. After inspection the company has been issued a Form FDA 483 (9/08) with three observations.
Ortin Laboratories is a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines in India. The company is engaged in manufacture of Pharma formulations.